Create
Log in
Enquire now
US Patent 10265324 Pharmaceutical compositions comprising meloxicam
Overview
Structured Data
Issues
Contributors
Access by API
Access by API
Is a
Patent
0
Date Filed
November 5, 2018
0
Date of Patent
April 23, 2019
0
Patent Application Number
16181086
0
Patent Citations
US Patent 10195279 Pharmaceutical compositions comprising meloxicam
US Patent 10137131 Pharmaceutical compositions comprising meloxicam
US Patent 10195278 Pharmaceutical compositions comprising meloxicam
US Patent 10058614 Pharmaceutical compositions comprising meloxicam
US Patent 10029010 Pharmaceutical compositions comprising meloxicam
Patent Citations Received
US Patent 11617755 Pharmaceutical compositions comprising meloxicam
0
US Patent 11471464 Pharmaceutical compositions comprising meloxicam
US Patent 11504429 Pharmaceutical compositions comprising meloxicam
US Patent 11510927 Pharmaceutical compositions comprising meloxicam
US Patent 11944683 Pharmaceutical compositions comprising meloxicam
0
US Patent 11998552 Pharmaceutical compositions comprising meloxicam
0
US Patent 12005118 Pharmaceutical compositions comprising meloxicam
0
US Patent 12128052 Pharmaceutical compositions comprising meloxicam
0
US Patent 10322181 Pharmaceutical compositions comprising meloxicam
US Patent 10369224 Pharmaceutical compositions comprising meloxicam
0
•••
Patent Inventor Names
Herriot Tabuteau
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
10265324
0
Patent Primary Examiner
Savitha M Rao
0
Find more entities like US Patent 10265324 Pharmaceutical compositions comprising meloxicam
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE